Zinzino group revenue increased with a total of 21 %, compared with the previous year.

 

The revenue in April for Zinzino's sales markets increased by 22 % and amounted to SEK 300.8 (246.6) million. Faun Pharma's external sales decreased and amounted to SEK 4.6 (6.1) million. Overall, the Group increased revenues by 21 % to SEK 305.4 (252.7) million compared with the previous year.

Accumulated revenue for January – April 2026 increased by 26 % to SEK 1,227.5 (976.3) million.

Revenues were distributed as follows:

Regions, MSEK	26-Apr	25-Apr	Change	YTD 2026	YTD 2025	Change
The Nordics	24.6	23.4	5%	103.0	100.4	3%
Central Europe	88.8	64.7	37%	364.4	261.1	40%
East Europe	26.1	27.1	-4%	111.3	124.3	-10%
South & West Europe	49.9	43.9	14%	206.6	168.9	22%
The Baltics	9.5	8.5	12%	38.8	37.2	4%
North America	70.4	51.6	36%	262.8	161.8	62%
South America	4.0	0.7	471%	15.8	3.0	427%
Asia-Pacific	25.6	25.2	2%	92.7	91.0	2%
Africa	1.9	1.5	27%	8.3	6.5	28%
Zinzino	300.8	246.6	22%	1,203.7	954.2	26%
Faun Pharma	4.6	6.1	-25%	23.8	22.1	8%
Zinzino Group	305.4	252.7	21%	1,227.5	976.3	26%

 

Countries in regions:

-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden

-Central Europe: Austria, Germany, Switzerland

-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania

-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands

-The Baltics: Estonia, Latvia, Lithuania

-North America: Canada, USA, Mexico

-South America: Peru, Colombia

-Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines, South Korea

-Africa: South Africa

 

For more information:

Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, dag@zinzino.com

Fredrik Nielsen CFO Zinzino +46 (0) 707 900 174, fredrik.nielsen@zinzino.com

 

Pictures for publication free of charge: marketing@zinzino.com

 

Certified Adviser: Tapper Partners AB